SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-043189
Filing Date
2017-08-14
Accepted
2017-08-14 16:32:11
Documents
62
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v472180_10q.htm 10-Q 623856
2 EXHIBIT 31.1 v472180_ex31-1.htm EX-31.1 8963
3 EXHIBIT 31.2 v472180_ex31-2.htm EX-31.2 8668
4 EXHIBIT 32.1 v472180_ex32-1.htm EX-32.1 4638
  Complete submission text file 0001144204-17-043189.txt   4698874

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20170630.xml EX-101.INS 1027866
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20170630.xsd EX-101.SCH 50855
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20170630_cal.xml EX-101.CAL 47085
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20170630_def.xml EX-101.DEF 285670
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20170630_lab.xml EX-101.LAB 374298
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20170630_pre.xml EX-101.PRE 326358
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 171030732
SIC: 2834 Pharmaceutical Preparations